> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# HHS Withdrawing FDA Compliance Guide on Unapproved Drugs
- URL: https://www.fdaweb.com/hhs-withdrawing-fda-compliance-guide-on-unapproved-drugs/
- Published: 2020-11-24T12:00:00.000Z
- Updated: 2026-09-14T16:37:54.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148150

*Federal Register* notice: HHS is announcing its intent to withdraw FDA’s *Marketed Unapproved Drugs – Compliance Policy Guide, Sec. 440.100,* *Marketed New Drugs Without Approved NDAs or ANDAs*, and to request information from the public regarding drugs that may be grandfathered or generally recognized as safe and effective. To view the notice, click [here](https://public-inspection.federalregister.gov/2020-26133.pdf?ref=fdaweb.com).